GE HealthCare announced a definitive agreement to acquire SOFIE Biosciences, a leading US-based CMO for PET radiopharmaceuticals, from Trilantic North America, for a purchase price of $945 million ...
Pharmexcil opens dedicated meeting spaces for Indian pharma visitors at CPhI Worldwide 2026: Our Bureau, Mumbai Wednesday, October 7, 2026, 09:00 Hrs [IST] India’s pharmaceutica ...
India’s ayurvedic clinics need to transform from traditional into reliable medical institutions: Dr Partap Chauhan: Nandita Vijayasimha, Bengaluru Wednesday, October 7, 2026, 08 ...
Animal diagnostics need to move from disease detection to prevention for public health and safety: Dr Maneesh Gupta: Shardul Nautiyal, Mumbai Wednesday, October 7, 2026, 08:00 Hrs ...
DCC rejects proposal for creation of digital platform to upload quality control & test reports of pharma cos: Our Bureau, New Delhi Wednesday, October 7, 2026, 08:00 Hrs [IST] The ...
Indian pharma moves towards specialty drug delivery driving better outcomes through patient-centric innovation: Nandita Vijayasimha, Bengaluru Wednesday, October 7, 2026, 08:00 Hr ...
Over 40% Haryana pharma units implement revised Schedule M; Rest to comply in 8-10 months: HPMA: Peethaambaran Kunnathoor, Chennai Wednesday, October 7, 2026, 08:00 Hrs [IST] In a ...
Healthcare sector in India is rapidly moving beyond physical interactions: Abhinav Parashar: Yash Ved, Mumbai Wednesday, October 7, 2026, 08:00 Hrs [IST] Healthcare sector in Indi ...
Ramesh Shankar Wednesday, October 7, 2026, 08:00 Hrs [IST] The Parliamentary Standing Committee on Union Ministry of Chemicals and Fert ...
Neuberg Diagnostics, one of India's leading integrated diagnostics groups, announced the consolidation of its Maharashtra operations with NM Medical, bringing together some of the diagnostic brands ...
Regency Hospital Limited, a leading tertiary care healthcare provider in Uttar Pradesh, has raised Rs. 110 crore from BlackSoil Capital to fund its expansion and investments in new healthcare ...
US FDA clears HanchorBio’s IND application for HCB303, a next-generation trispecific immunotherapy: Taipei, Shanghai Tuesday, October 6, 2026, 18:00 Hrs [IST] HanchorBio, Inc., ...